1. NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE ACTION Project & news EUROCHIP-2 THE ACTION Project & news Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE - GENERAL www.tumori.net/eurochip

2. WHAT IS THE EUROCHIP-2 THE ACTION PROJECT? It is a translational research project (from epidemiology to public health) It is a project against disparities It is an EC project It aims to research ways to promote health by EU imprimatur Its goal is to promote public health actions against cancer in each EU country It works in the building of an European platform for cancer control

3. EUROPE WITHIN THE WORLD AGE-STANDARDIZED INCIDENCE RATES Source: GLOBOCAN 2002, IARC. Age-Standardised (World) rates, per 100,000

4. EUROPE WITHIN THE WORLD Source: GLOBOCAN 2002, IARC. Age-Standardised (World) rates, per 100,000 AGE-STANDARDIZED MORTALITY RATES

5. All cancers combined: Europe

6. Differences in Europe. Relative risks (Max/Min). All cancers combined YearMalesFemales Mortality 1985 2.31.8 1996 4.31.9 Incidence 1985 1.9 1996 1.92.2 5-yrs Survival 1985-89 2.22.0 1990-94 2.52.0 Sources: EUROCIM - EUROCARE Data from cancer registries of these countries Austria, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom

7. Disks are proportional to the national health expenditure ($ PPP) $ PPP: Parity Purchasing Power per capita (US $) Sourcesi: OECD 2002 and EUROCARE -3 GDP (1997) and 5-year cancer survival

8. INDICATOR A INDICATOR B INDICATOR C. INDICATOR Z INDICATOR A INDICATOR B INDICATOR C. INDICATOR Z INFORMATION ANALYSIS ACTIONS

9. GENERAL AIMS OF EUROCHIP-2 1.To extend the collaboration 2.To promote national groups in each country 3.To analyse the behaviour of available indicators 4.To discuss on deficiencies at national and international level 5.To promote at least one important ACTION in each country

10. EUROCHIP-2: MAP

11. EUROCHIP-2 DISCUSSION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4 ACTION5ACTION5 ACTION6ACTION6 ACTION6ACTION6 EUROPEAN PUBLIC HEALTH ACTION – early diagnosis Cervical screening EUROPEAN PUBLIC HEALTH ACTION – care & treatment Pilot studies EUROPEAN PUBLIC HEALTH ACTION - prevention Dietary prevention EU CANCER PLAN

12. UTERUS CANCER STANDARDIZED MORTALITY RATE AGE: 20 – 44 (IN THESE AGES MOSTLY CERVICAL CANCER) European standard per 100,000 http://epicancer.iss.it PILLAR 1 EARLY DIAGNOSIS

13. -Describe the opportunistic/programmed cervical cancer screening in those countries at present time -For countries without cervical screening programs: find difficulties and problems with specific assessment studies in these Eastern European countries -For countries with cervical screening programs: to help specific activities that at the moment are not subsidize -To create relations with groups of pressure with national health ministries and with European Parliament -To share information with other networks ( EUNICE, European Cancer Screening networks) EUROCHIP-2 ACTION: TASK FORCE ON CERVICAL CANCER SCREENING AIMS ACTION 1

14. ASSESSMENT PHASES: COLLECTION OF INFO ON Use of Policies, Guidelines, and Norms Program Management Issues Health Services Information and Education Activities Community Perspectives Laboratory Information Systems ROMANIA

15. Screening prices VS treatment prices In Bulgaria the mean value of programme screening for 1 person is around 5 € Target population: 1.8 million (age 25-60) Screening interval: 3 years 5 € * 0.6 million = 3 million € per year V. Zlatkov - Bulgaria (2006) BULGARIA Cervical cancer stages Number of cases in Bulgaria (2001) Prices according to EU data (Andrae Bengt - 2004) Per itemTotal St. III – IV34730 000 €10 410 000 € St. I – II6709 000 €6 030 000 € CIS275 300 €83 500 € Total1292-16 522 500 € BULGARIAN ESTIMATES

16. ESTONIA PROBLEMS OF THE ORGANISED SCREENING PROGRAM P. Veerus - Estonia (2006) Low participation: Only 21.7% of the 12,960 invited women attended the screening No funds for screening registry No invitation of women without insurance (~5% of population) To use experience from other countries to produce successful campaigns Group of pressure for invitation of women without insurance Money for starting the organization of screening registry

17. EUROCHIP FUND 1.Budget: 17.500 € - Only for personnel costs 2.Involvement of personnel for ACTIONS 3.Money sent: Directly to personnelOR To Institute involved in the project 4.Necessary admin. documentation (at the end of the work) Declaration of money receipt (by personnel) Declaration of personnel payment (by Institute)

18. EUROCHIP-2 FUNDS: THE ACTION IN LATVIA